S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   164.96 (-1.25%)
MSFT   399.36 (-1.21%)
META   483.88 (-3.57%)
GOOGL   153.97 (-1.31%)
AMZN   174.95 (-2.38%)
TSLA   148.99 (-0.63%)
NVDA   801.70 (-5.32%)
AMD   149.10 (-3.86%)
NIO   3.83 (-4.25%)
BABA   68.89 (+0.01%)
T   16.35 (+0.12%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   149.12 (-2.50%)
CGC   8.09 (+3.32%)
DIS   112.09 (-0.30%)
AMC   3.23 (+10.62%)
PFE   25.79 (+1.58%)
PYPL   62.18 (+0.13%)
XOM   119.90 (+1.16%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   164.96 (-1.25%)
MSFT   399.36 (-1.21%)
META   483.88 (-3.57%)
GOOGL   153.97 (-1.31%)
AMZN   174.95 (-2.38%)
TSLA   148.99 (-0.63%)
NVDA   801.70 (-5.32%)
AMD   149.10 (-3.86%)
NIO   3.83 (-4.25%)
BABA   68.89 (+0.01%)
T   16.35 (+0.12%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   149.12 (-2.50%)
CGC   8.09 (+3.32%)
DIS   112.09 (-0.30%)
AMC   3.23 (+10.62%)
PFE   25.79 (+1.58%)
PYPL   62.18 (+0.13%)
XOM   119.90 (+1.16%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   164.96 (-1.25%)
MSFT   399.36 (-1.21%)
META   483.88 (-3.57%)
GOOGL   153.97 (-1.31%)
AMZN   174.95 (-2.38%)
TSLA   148.99 (-0.63%)
NVDA   801.70 (-5.32%)
AMD   149.10 (-3.86%)
NIO   3.83 (-4.25%)
BABA   68.89 (+0.01%)
T   16.35 (+0.12%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   149.12 (-2.50%)
CGC   8.09 (+3.32%)
DIS   112.09 (-0.30%)
AMC   3.23 (+10.62%)
PFE   25.79 (+1.58%)
PYPL   62.18 (+0.13%)
XOM   119.90 (+1.16%)
S&P 500   4,997.81 (-0.27%)
DOW   38,091.03 (+0.84%)
QQQ   416.75 (-1.57%)
AAPL   164.96 (-1.25%)
MSFT   399.36 (-1.21%)
META   483.88 (-3.57%)
GOOGL   153.97 (-1.31%)
AMZN   174.95 (-2.38%)
TSLA   148.99 (-0.63%)
NVDA   801.70 (-5.32%)
AMD   149.10 (-3.86%)
NIO   3.83 (-4.25%)
BABA   68.89 (+0.01%)
T   16.35 (+0.12%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   149.12 (-2.50%)
CGC   8.09 (+3.32%)
DIS   112.09 (-0.30%)
AMC   3.23 (+10.62%)
PFE   25.79 (+1.58%)
PYPL   62.18 (+0.13%)
XOM   119.90 (+1.16%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Astrotech Co. stock logo
ASTC
Astrotech
$9.53
-0.1%
$8.55
$7.00
$15.11
$16.20M-0.173,390 shs367 shs
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
$0.83
+7.7%
$1.00
$0.73
$11.90
$17.97M0.52118,171 shs31,843 shs
Precipio, Inc. stock logo
PRPO
Precipio
$6.20
-7.6%
$6.41
$4.75
$14.80
$8.87M1.616,366 shs1,603 shs
Scientific Industries, Inc. stock logo
SCND
Scientific Industries
$1.30
-5.8%
$1.77
$0.18
$5.17
$9.10M0.0713,517 shs5,100 shs
Talis Biomedical Co. stock logo
TLIS
Talis Biomedical
$8.99
-0.1%
$8.50
$4.35
$9.32
$16.36M1.748,585 shs3,652 shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Astrotech Co. stock logo
ASTC
Astrotech
0.00%-2.65%+9.03%+27.71%-9.14%
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
+4.55%-14.44%-20.63%-37.40%-88.68%
Precipio, Inc. stock logo
PRPO
Precipio
0.00%+0.86%+7.28%-2.69%-50.14%
Scientific Industries, Inc. stock logo
SCND
Scientific Industries
-5.80%-16.13%-23.98%-40.91%-71.11%
Talis Biomedical Co. stock logo
TLIS
Talis Biomedical
+6.51%+6.38%-1.85%+12.36%+29.31%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Astrotech Co. stock logo
ASTC
Astrotech
N/AN/AN/AN/AN/AN/AN/AN/A
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
3.5154 of 5 stars
2.33.00.04.72.42.50.6
Precipio, Inc. stock logo
PRPO
Precipio
0.3361 of 5 stars
2.03.00.00.00.00.80.6
Scientific Industries, Inc. stock logo
SCND
Scientific Industries
N/AN/AN/AN/AN/AN/AN/AN/A
Talis Biomedical Co. stock logo
TLIS
Talis Biomedical
0.2543 of 5 stars
0.54.00.00.00.02.50.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Astrotech Co. stock logo
ASTC
Astrotech
N/AN/AN/AN/A
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
2.50
Moderate Buy$1.0020.55% Upside
Precipio, Inc. stock logo
PRPO
Precipio
N/AN/A$40.00545.16% Upside
Scientific Industries, Inc. stock logo
SCND
Scientific Industries
N/AN/AN/AN/A
Talis Biomedical Co. stock logo
TLIS
Talis Biomedical
1.00
Sell$5.00-44.38% Downside

Current Analyst Ratings

Latest AXDX, SCND, TLIS, ASTC, and PRPO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/2/2024
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/1/2024
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$2.00 ➝ $1.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Astrotech Co. stock logo
ASTC
Astrotech
$750K21.60N/AN/A$26.55 per share0.36
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
$12.06M1.49N/AN/A($1.37) per share-0.61
Precipio, Inc. stock logo
PRPO
Precipio
$15.20M0.58N/AN/A$10.16 per share0.61
Scientific Industries, Inc. stock logo
SCND
Scientific Industries
$11.11M0.82N/AN/A$1.98 per share0.66
Talis Biomedical Co. stock logo
TLIS
Talis Biomedical
$2.13M7.68N/AN/A$37.95 per share0.24

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Astrotech Co. stock logo
ASTC
Astrotech
-$9.64M-$6.30N/AN/A-515.23%-23.57%-22.21%5/9/2024 (Estimated)
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
-$61.62M-$4.89N/AN/AN/A-454.95%N/A-170.54%5/9/2024 (Estimated)
Precipio, Inc. stock logo
PRPO
Precipio
-$5.85M-$4.56N/AN/A-38.51%-51.75%-37.93%5/10/2024 (Estimated)
Scientific Industries, Inc. stock logo
SCND
Scientific Industries
-$9.09MN/A0.00N/A-81.78%-75.50%-60.26%N/A
Talis Biomedical Co. stock logo
TLIS
Talis Biomedical
-$62.01M-$34.18N/AN/A-2,905.67%-69.49%-54.15%5/9/2024 (Estimated)

Latest AXDX, SCND, TLIS, ASTC, and PRPO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/12/2024Q2 2024
Astrotech Co. stock logo
ASTC
Astrotech
N/A-$1.62-$1.62-$1.62N/A$1.12 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Astrotech Co. stock logo
ASTC
Astrotech
N/AN/AN/AN/AN/A
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
N/AN/AN/AN/AN/A
Precipio, Inc. stock logo
PRPO
Precipio
N/AN/AN/AN/AN/A
Scientific Industries, Inc. stock logo
SCND
Scientific Industries
N/AN/AN/AN/AN/A
Talis Biomedical Co. stock logo
TLIS
Talis Biomedical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Astrotech Co. stock logo
ASTC
Astrotech
N/A
17.31
16.42
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
N/A
2.03
1.76
Precipio, Inc. stock logo
PRPO
Precipio
0.01
1.17
1.05
Scientific Industries, Inc. stock logo
SCND
Scientific Industries
N/A
6.72
4.06
Talis Biomedical Co. stock logo
TLIS
Talis Biomedical
N/A
8.86
8.86

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Astrotech Co. stock logo
ASTC
Astrotech
24.35%
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
17.14%
Precipio, Inc. stock logo
PRPO
Precipio
10.45%
Scientific Industries, Inc. stock logo
SCND
Scientific Industries
N/A
Talis Biomedical Co. stock logo
TLIS
Talis Biomedical
43.77%

Insider Ownership

CompanyInsider Ownership
Astrotech Co. stock logo
ASTC
Astrotech
11.50%
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
33.00%
Precipio, Inc. stock logo
PRPO
Precipio
10.60%
Scientific Industries, Inc. stock logo
SCND
Scientific Industries
17.98%
Talis Biomedical Co. stock logo
TLIS
Talis Biomedical
46.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Astrotech Co. stock logo
ASTC
Astrotech
221.70 million1.51 millionNot Optionable
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
17921.66 million14.52 millionOptionable
Precipio, Inc. stock logo
PRPO
Precipio
511.43 million1.28 millionOptionable
Scientific Industries, Inc. stock logo
SCND
Scientific Industries
787.00 million5.75 millionNot Optionable
Talis Biomedical Co. stock logo
TLIS
Talis Biomedical
1021.82 million984,000No Data

AXDX, SCND, TLIS, ASTC, and PRPO Headlines

SourceHeadline
Talis Biomedical Corporation (TLIS)Talis Biomedical Corporation (TLIS)
finance.yahoo.com - March 31 at 8:16 AM
Grabar Law Office Investigates Claims on Behalf of Shareholders of Talis Biomedical CorporationGrabar Law Office Investigates Claims on Behalf of Shareholders of Talis Biomedical Corporation
markets.businessinsider.com - February 16 at 8:42 PM
TLIS Feb 2024 2.500 putTLIS Feb 2024 2.500 put
finance.yahoo.com - February 15 at 2:52 AM
Peninsula diagnostics company to close Redwood City labs and offices, pursue strategic alternativesPeninsula diagnostics company to close Redwood City labs and offices, pursue 'strategic alternatives'
bizjournals.com - November 14 at 8:38 PM
Talis Biomedical Corporation: Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashTalis Biomedical Corporation: Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
finanznachrichten.de - November 14 at 3:36 PM
LICY, BTAI and HROW among mid-day moversLICY, BTAI and HROW among mid-day movers
msn.com - November 14 at 3:36 PM
Talis reviewing strategic alternatives, stock rallies 35%Talis reviewing strategic alternatives, stock rallies 35%
msn.com - November 14 at 3:36 PM
Why Talis Biomedical (TLIS) Stock Is Exploding HigherWhy Talis Biomedical (TLIS) Stock Is Exploding Higher
msn.com - November 14 at 3:36 PM
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashTalis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
finance.yahoo.com - November 14 at 3:36 PM
Biomedical Engineering (BME) and Biomedical Science (BMS) ProgramsBiomedical Engineering (BME) and Biomedical Science (BMS) Programs
drexel.edu - October 23 at 1:39 AM
BTIG Maintains Talis Biomedical (TLIS) Sell RecommendationBTIG Maintains Talis Biomedical (TLIS) Sell Recommendation
msn.com - August 16 at 3:29 PM
BTIG Maintains Sell Rating for Talis Biomedical: Heres What You Need To KnowBTIG Maintains Sell Rating for Talis Biomedical: Here's What You Need To Know
markets.businessinsider.com - August 16 at 3:29 PM
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business UpdateTalis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
finance.yahoo.com - August 11 at 12:45 AM
A Preview Of Talis Biomedicals EarningsA Preview Of Talis Biomedical's Earnings
benzinga.com - August 9 at 2:02 PM
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
finance.yahoo.com - August 3 at 12:25 PM
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
finance.yahoo.com - August 2 at 12:20 PM
TLIS - Talis Biomedical CorporationTLIS - Talis Biomedical Corporation
uk.finance.yahoo.com - August 1 at 4:18 PM
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price RequirementTalis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement
finance.yahoo.com - July 24 at 10:12 AM
Talis Biomedical Announces 1-for-15 Reverse Stock SplitTalis Biomedical Announces 1-for-15 Reverse Stock Split
finance.yahoo.com - July 5 at 9:12 AM
Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent DirectorTalis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director
finance.yahoo.com - May 23 at 1:12 PM
Talis Biomedical Corporation: Talis Biomedical Announces Business Update and First Quarter 2023 Financial ResultsTalis Biomedical Corporation: Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results
finanznachrichten.de - May 12 at 8:33 AM
Talis Biomedical reports Q1 resultsTalis Biomedical reports Q1 results
seekingalpha.com - May 11 at 8:53 PM
Talis Biomedical: Q1 Earnings InsightsTalis Biomedical: Q1 Earnings Insights
msn.com - May 11 at 8:53 PM
Talis Biomedical Corporation (TLIS) Investor News: Robbins LLP Reminds Investors it is Investigating TLIS on Behalf of ShareholdersTalis Biomedical Corporation (TLIS) Investor News: Robbins LLP Reminds Investors it is Investigating TLIS on Behalf of Shareholders
benzinga.com - May 9 at 1:50 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Astrotech logo

Astrotech

NASDAQ:ASTC
Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, cargo and other secured facilities, and borders. In addition, it develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.
Accelerate Diagnostics logo

Accelerate Diagnostics

NASDAQ:AXDX
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. The company was incorporated in 1982 and is headquartered in Tucson, Arizona.
Precipio logo

Precipio

NASDAQ:PRPO
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.
Scientific Industries logo

Scientific Industries

OTCMKTS:SCND
Scientific Industries, Inc. engages in the design, manufacture, and marketing of benchtop laboratory equipment and bioprocessing systems worldwide. It offers vortex mixers to mix the contents of test tubes, beakers, and other containers by placing such containers on a rotating cup or other attachments; and various mixers and shakers, such as high-speed touch mixers, mixers with an integral timer, cell disruptors, microplate mixers, vortex mixers incorporating digital control and display, multi-vessel vortex mixers, and orbital shakers. The company also provides benchtop multi-purpose rotators and rockers, designed to rotate and rock various containers; refrigerated incubators and incubated shakers for shaking and stirring functions; and high/low programmable magnetic stirrer, four-place high/low programmable magnetic, large volume magnetic, and four-place general purpose stirrers. In addition, it offers bioprocessing systems, including cell growth quantifier for biomass monitoring in shake flasks, liquid injection system for automated feeding in shake flasks, and various coaster systems and flow-through cells for pH and DO monitoring and analytical software; and moisture analyzers, automated pill counters, test stands, and force gauges, as well as pharmacy, laboratory, and industrial digital scales. The company's products are used for research purposes by universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, and other industries performing laboratory-scale research. It markets its products under the Genie and Torbal brand names directly to customers, as well as through laboratory equipment distributors and online. The company was incorporated in 1954 and is headquartered in Bohemia, New York.
Talis Biomedical logo

Talis Biomedical

NASDAQ:TLIS
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also develops Talis One tests for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B. The company was incorporated in 2013 and is headquartered in Redwood, California.